Freedom Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,169
| Closed | -$206K | – | 894 |
|
|
2021
Q1 | $206K | Buy |
+2,169
| New | +$206K | 0.02% | 784 |
|
|
2019
Q2 | – | Sell |
-5,090
| Closed | -$399K | – | 714 |
|
|
2019
Q1 | $399K | Buy |
+5,090
| New | +$399K | 0.03% | 439 |
|
|
2018
Q2 | – | Sell |
-13,815
| Closed | -$1.42M | – | 1039 |
|
|
2018
Q1 | $1.42M | Buy |
13,815
+215
| +2% | +$22.1K | 0.07% | 267 |
|
|
2017
Q4 | $1.16M | Buy |
13,600
+431
| +3% | +$36.8K | 0.06% | 306 |
|
|
2017
Q3 | $1.12M | Sell |
13,169
-631
| -5% | -$53.6K | 0.06% | 298 |
|
|
2017
Q2 | $1.05M | Buy |
13,800
+82
| +0.6% | +$6.21K | 0.06% | 300 |
|
|
2017
Q1 | $906K | Sell |
13,718
-3,673
| -21% | -$243K | 0.05% | 327 |
|
|
2016
Q4 | $1.1M | Sell |
17,391
-2,813
| -14% | -$178K | 0.07% | 214 |
|
|
2016
Q3 | $1.29M | Buy |
20,204
+17
| +0.1% | +$1.08K | 0.08% | 177 |
|
|
2016
Q2 | $1.5M | Buy |
20,187
+1,113
| +6% | +$82.8K | 0.1% | 121 |
|
|
2016
Q1 | $1.27M | Buy |
+19,074
| New | +$1.27M | 0.09% | 163 |
|